BRCA1 and neoplasm: The three germline BRCA1/2 pathogenic variants not detected in tumour DNA were all large rearrangements and included two BRCA1 Exon 13 duplications (n = 2) and a BRCA2 Exon 1–24 deletion (n = 1; Table 4).